Question Title

* 1. After participating in this activity, how confident are you in the management of patients with AML in your practice?

Question Title

* 2. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 3. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 4. What barriers do you see to making changes in your practice?

Question Title

* 5. Please rate your level of agreement by checking the appropriate rating.
5 = Strongly agree, 4 = Agree, 3 = Neutral, 2 = Disagree, 1 = Strongly disagree

After participating in today’s activity, I am now better able to:

  Strongly agree Agree Neutral Disagree Strongly disagree
Correlate disease pathophysiology, cytogenetic, and molecular characteristics with targeted agents to individualize treatment of patients with acute myeloid leukemia (AML)
Evaluate recent changes to the standard treatment paradigm for newly diagnosed and relapsed/refractory patients with AML
Analyze data supporting best practice use of maintenance therapy
Evaluate methods for measuring minimal residual disease (MRD) after complete remission to determine risk of relapse

Question Title

* 6. The content presented:

  Strongly agree Agree Neutral Disagree Strongly disagree
Enhanced my current knowledge base
Addressed my most pressing questions
Promoted improvements or quality in health care
Was scientifically rigorous and evidence based
Avoided commercial bias or influence

Question Title

* 7. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 8. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 9. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for this or related disease state:

T